This infographic details the 2026 ESC diagnosis pathway for HFpEF, stressing that a normal resting echo doesn’t rule out early disease. Highlighting echo’s diagnostic uncertainty, it builds a strong case for Vivio as a superior, non-invasive tool to identify Stage B heart failure, even before ESC guidelines recognize non-invasive LVEDP measurement. Source: Harefield Echocardiography